Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

Add To Watchlist

TSX:AEZS - Post Discussion

COSCIENS Biopharma Inc > See what comes next?

View:

Post by prophetoffactz on Jul 11, 2024 7:34pm

See what comes next?

"...we believe we are poised to significantly propel the Company into its next phase of growth and unlock value as a diversified biopharmaceutical company,” stated Gilles Gagnon, M.Sc., MBA, President and CEO of Ceapro." May 29, 2024

Ronald W. Miller, Chair of the Company: “With the successful completion of this merger, we are now optimized to bring value-driving, transformational products to the market.” June 3, 2024